Close Menu

Color Genomics

The test was first authorized in May for the detection of the SARS-CoV-2 N, E, and ORF1a genes in nasopharyngeal swabs and other specimens.

The consortium seeks to accelerate research and clinical diagnostic applications through collaboration with the ultimate goal of improving COVID-19 testing.

The pilot program will allow passengers leaving from San Francisco to take Abbott's rapid test at the airport or a mail-in test from Color before their flight.

Color Genomics' kit is designed for the unmonitored self-collection of nasal swab specimens for SARS-CoV-2 testing.

screening assay NEB colorimetric reagents

Grassroots efforts are leading the way in a number of commercial and non-commercial screening tests in development.

News items for the week of July 27, 2020. 

A number of diagnostic labs have considered saliva-based SARS-CoV-2 testing but decided against it, while other groups continue to pursue it.

Issued last week, the guidance said insurers were not required to reimburse such testing, which could impact coverage in schools, workplaces, and other settings.

With students and faculty scheduled to return in a few months, institutions are reaching out to secure testing to help keep the virus in check on campus.

Launched by both national labs and regional and specialty firms, the offerings provide testing as well as guidance on how to best structure testing programs.

Pages